Is AVCNF or JNJ a better dividend investment in 2026?

AVCNF currently yields 1666.67% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: AVCNF offers higher current income.

What is the dividend yield difference between AVCNF and JNJ?

AVCNF has a forward dividend yield of 1666.67% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 1663.31 percentage points.

Home › Compare › AVCNF vs JNJ

AVCNF vs JNJ: Dividend Comparison 2026

AVCNF yields 1666.67% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 AVCNF wins by $1839785666.24M in total portfolio value

INVESTMENT

TIME HORIZON10 years

AVCNF

● Live price

1666.67%

Share price

$0.12

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1839785666.26M

Annual income

$1,645,561,548,268,653.00

Full AVCNF calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — AVCNF vs JNJ

📍 AVCNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	AVCNF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, AVCNF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

AVCNF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AVCNF

Annual income on $10K today (after 15% tax)

$141,666.67/yr

After 10yr DRIP, annual income (after tax)

$1,398,727,316,028,355.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, AVCNF beats the other by $1,398,727,316,027,651.50/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AVCNF + JNJ for your $10,000?

AVCNF: 50%JNJ: 50%

100% JNJ50/50100% AVCNF

Portfolio after 10yr

$919892833.14M

Annual income

$822,780,774,134,740.40/yr

Blended yield

89.44%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

AVCNF

No analyst data

Altman Z

-4.8

Piotroski

3/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AVCNF buys

JNJ buys

No recent congressional trades found for AVCNF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricAVCNFJNJ

Forward yield	1666.67% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$1839785666.26M ✓	$20.0K
Annual income after 10y	$1,645,561,548,268,653.00 ✓	$827.78
Total dividends collected	$1825787439.21M ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: AVCNF vs JNJ ($10,000, DRIP)

Year	AVCNF Portfolio	AVCNF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$177,367	$166,666.67	$10,676	$355.77	+$166.7K → AVCNF
2	$2,952,503	$2,762,720.66	$11,407	$389.39	+$2.94M → AVCNF
3	$46,139,686	$42,980,507.73	$12,198	$426.53	+$46.13M → AVCNF
4	$677,098,258	$627,728,794.51	$13,056	$467.62	+$677.09M → AVCNF
5	$9,333,745,461	$8,609,250,324.41	$13,987	$513.12	+$9333.73M → AVCNF
6	$120,900,966,251	$110,913,858,608.07	$14,998	$563.56	+$120900.95M → AVCNF
7	$1,472,054,345,780	$1,342,690,311,890.92	$16,098	$619.52	+$1472054.33M → AVCNF
8	$16,853,789,214,559	$15,278,691,064,574.45	$17,295	$681.69	+$16853789.20M → AVCNF
9	$181,517,867,281,133	$163,484,312,821,554.84	$18,599	$750.82	+$181517867.26M → AVCNF
10	$1,839,785,666,259,465	$1,645,561,548,268,653.00	$20,022	$827.78	+$1839785666.24M → AVCNF

AVCNF vs JNJ: Complete Analysis 2026

AVCNF — Stock

Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research and development of evidence-based products for consumer medical and pharmaceutical segments worldwide. The company collaborates with Canadian academic and medical institutions. Its scientific platform includes research and development, and clinical development that leads to the commercialization of approximately twenty products across four main market segments. The company provides medical and wellness products containing cannabidiol, cannabigerol, and tetrahydrocannabinol under the RHO Phyto brand; functional CBD consumer derma-cosmetic and topical products under the Pura H&W and Pura Earth brand names; and cannabis dried flowers, standardized seeds, full spectrum extracts, cannabinoid distillates, isolated cannabinoids, and bulk formulations derived from hemp and cannabis cultivars under the Aureus brand. It also develops pharmaceutical products for epidermolysis bullosa, dermatology, chronic pain, and various neurological disorders. The company has research collaboration with Dr. Christine Allen'sResearch Group for the development of a cannabinoid-based treatment for lung inflammation associated with COVID19. Avicanna Inc. was incorporated in 2016 and is headquartered in Toronto, Canada.

Full AVCNF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this AVCNF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AVCNF vs SCHD AVCNF vs JEPI AVCNF vs O AVCNF vs KO AVCNF vs MAIN AVCNF vs ABBV AVCNF vs MRK AVCNF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.